| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.523 | 14.772 | 20.393 | 18.725 | 14.323 | 28.593 | 16.313 | 13.398 | 16.633 | 12.158 |
| Total Income - EUR | 6.270 | 16.335 | 78.783 | 21.516 | 39.988 | 55.758 | 40.954 | 43.235 | 26.111 | 22.020 |
| Total Expenses - EUR | 12.095 | 21.820 | 39.965 | 21.913 | 35.990 | 39.557 | 43.142 | 51.707 | 23.540 | 68.420 |
| Gross Profit/Loss - EUR | -5.825 | -5.485 | 38.818 | -397 | 3.999 | 16.201 | -2.188 | -8.472 | 2.571 | -46.400 |
| Net Profit/Loss - EUR | -6.179 | -5.792 | 37.817 | -959 | 3.436 | 15.340 | -2.740 | -8.960 | 2.571 | -46.400 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Prolact Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 13.621 | 10.609 | 37.387 | 31.082 | 10.546 | 5.089 | 0 | 0 |
| Current Assets | 5.471 | 20.939 | 30.831 | 25.586 | 36.506 | 68.593 | 57.694 | 69.073 | 76.600 | 23.234 |
| Inventories | 0 | 13.784 | 5.144 | 5.050 | 5.036 | 4.941 | 4.831 | 4.846 | 4.832 | 4.805 |
| Receivables | 2.778 | 4.778 | 17.599 | 20.672 | 7.022 | 29.133 | 9.142 | 13.900 | 24.207 | 15.153 |
| Cash | 2.692 | 2.378 | 8.088 | -135 | 24.447 | 34.518 | 43.721 | 50.326 | 47.562 | 3.276 |
| Shareholders Funds | -6.132 | -11.862 | 26.156 | 24.717 | 27.674 | 42.490 | 38.808 | 29.968 | 32.448 | -14.133 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 11.603 | 32.801 | 18.297 | 11.478 | 46.219 | 57.184 | 29.433 | 44.194 | 44.152 | 37.367 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "141 - 141" | |||||||||
| CAEN Financial Year |
141
|
|||||||||
Comments - Prolact Bio Srl